K.U.Leuven
  Search for Staff Students Organisational chart Search matrix Keywords
Home  
Alzheimers Disease  
Research Projects  
AAV models  
pt
Transgenic Mouse Models  
Publications  
 
Laboratory Members  
Seminar  
Contact  
Links  
 
Faculty  
Library  
 
 

Experimental Genetics Group

Bolleke Abstract   Pijltje
Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice.

Am J Pathol. 2006 Jan;168(1):245-60.

Van Dooren T1, Muyllaert D1, Borghgraef P1, Cresens A2, Devijver H1, Van der Auwera I2, Wera S2, Dewachter I1, Van Leuven F1.

1Department Human Genetics, Experimental Genetics Group, Katholieke Universiteit Leuven, Leuven, Belgium.
2reMYND nv, Leuven, Belgium.

Apolipoprotein E4 (ApoE4) is associated with Alzheimer's disease by unknown mechanisms. We generated six transgenic mice strains expressing human ApoE4 in combination with mutant amyloid precursor protein (APP) and mutant presenilin-1 (PS1) in single-, double-, or triple-transgenic combinations. Diffuse, but not dense, amyloid plaque-load in subiculum and cortex was increased by neuronal but not glial ApoE4 in old (15 months) double-transgenic mice, whereas both diffuse and dense plaques formed in thalamus in both genotypes. Neuronal and glial ApoE4 promoted cerebral amyloid angiopathy as extensively as mutant PS1 but with pronounced regional differences: cortical angiopathy was induced by neuronal ApoE4 while thalamic angiopathy was again independent of ApoE4 source. Angiopathy correlated more strongly with soluble Abeta40 and Abeta42 levels in cortex than in thalamus throughout the six genotypes. Neither neuronal nor glial ApoE4 affected APP proteolytic processing, as opposed to mutant PS1. Neuronal ApoE4 increased soluble amyloid levels more than glial ApoE4, but the Abeta42/40 ratios were similar, although significantly higher than in single APP transgenic mice. We conclude that although the cellular origin of ApoE4 differentially affects regional amyloid pathology, ApoE4 acts on the disposition of amyloid peptides downstream from their excision from APP but without induction of tauopathy.

pdf FULL TEXT
K.U.Leuven - CWIS Copyright © Katholieke Universiteit Leuven | Comments on the content: Fred Van Leuven
Production:Annick Vogels| Most recent update: October 21, 2009 | Disclaimer
URL: http://med.kuleuven.be/legtegg/